Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Symcel Nabs SEK5.6m To Take Calorimetry Tech Into Medical Dx

This article was originally published in Clinica

Executive Summary

Swedish firm Symcel has set its sights on the medical diagnostics field, in particular the area of antibiotic drug resistance, as part of a strategy to expand its calScreener calorimetric technology for cell-based assay beyond the current drug discovery and academic research applications.


Related Content

New Head For SymCel To Push Commercial Phase





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts